🇺🇸·8h agoResearch
How Much Is Enough? Ultra-Low Doses of Immunotherapy to Improve Access and Affordability
Publisher
A
ASCO JCO Journal
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ascopubs.org
Leave the platform to read the original full article on the publisher site.
Source: ASCO JCO Journal
Scope: Research
Related coverage
More related coverage
UNMC·8h ago
Study suggests link between prenatal exposure to certain medications and increased autism risk
ASCO JCO Journal·8h ago
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update
ASCO JCO Journal·8h ago
When the System Is the Treatment: Rethinking Nonpharmacologic Breakthroughs in Oncology
ASCO JCO Journal·8h ago